Bank of New York Mellon
PRCT icon

Bank of New York Mellon’s Procept Biorobotics PRCT Stock Holding History

Bank of New York Mellon’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Buy
159,915
+14,080
+10% +$353K ﹤0.01% 2632
2026
Q1 		$3.65M Sell
145,835
-3,274
-2% -$92.3K ﹤0.01% 2492
2025
Q4 		$4.69M Sell
149,109
-40,683
-21% -$1.35M ﹤0.01% 2360
2025
Q3 		$6.77M Buy
189,792
+7,614
+4% +$348K ﹤0.01% 2149
2025
Q2 		$10.5M Buy
182,178
+5,500
+3% +$311K ﹤0.01% 1875
2025
Q1 		$10.3M Sell
176,678
-70,667
-29% -$4.82M ﹤0.01% 1838
2024
Q4 		$19.9M Buy
247,345
+24,974
+11% +$2.13M ﹤0.01% 1568
2024
Q3 		$17.8M Sell
222,371
-78,442
-26% -$5.57M ﹤0.01% 1644
2024
Q2 		$18.4M Sell
300,813
-25,200
-8% -$1.5M ﹤0.01% 1635
2024
Q1 		$16.1M Buy
326,013
+185,720
+132% +$8.84M ﹤0.01% 1699
2023
Q4 		$5.88M Buy
140,293
+11,561
+9% +$394K ﹤0.01% 2274
2023
Q3 		$4.22M Buy
128,732
+7,035
+6% +$240K ﹤0.01% 2403
2023
Q2 		$4.3M Buy
121,697
+31,834
+35% +$1.05M ﹤0.01% 2405
2023
Q1 		$2.55M Sell
89,863
-1,830
-2% -$64.5K ﹤0.01% 2662
2022
Q4 		$3.81M Sell
91,693
-15,881
-15% -$682K ﹤0.01% 2494
2022
Q3 		$4.46M Buy
107,574
+19,607
+22% +$782K ﹤0.01% 2345
2022
Q2 		$2.88M Buy
87,967
+65,888
+298% +$2.4M ﹤0.01% 2630
2022
Q1 		$772K Buy
22,079
+8,265
+60% +$199K ﹤0.01% 3462
2021
Q4 		$346K Buy
+13,814
New +$511K ﹤0.01% 4018

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon's PRCT Position: Q2 2026 in Review

Bank of New York Mellon increased its Procept Biorobotics (PRCT) stake by 9.7% in Q2 2026, buying an estimated $353K and bringing the position to 159,915 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2632.

Bank of New York Mellon first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $19.9M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bank of New York Mellon held 159,915 shares of Procept Biorobotics worth $3.61M as of Q2 2026.
  • Bank of New York Mellon bought 14,080 Procept Biorobotics shares in Q2 2026, an estimated $353K.
  • Procept Biorobotics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2632 holding.
  • Bank of New York Mellon first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Bank of New York Mellon's Procept Biorobotics position peaked at $19.9M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.